Tapentadol in the treatment of osteoarthritis: pharmacological rationale and clinical evidence

References

• Wenham CY, Conaghan PG. New horizons in osteoarthritis. Age Ageing. 2013;42(3):272–278. doi:10.1093/ageing/aft04323568255
   PubMed Web of Science ®Google Scholar
• Kim JR, Yoo JJ, Kim HA. Therapeutics in osteoarthritis based on an understanding of its molecular pathogenesis. Int J Mol Sci. 2018;19(3):E674. doi:10.3390/ijms1903067429495538
   PubMed Web of Science ®Google Scholar
• Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287–333. doi:10.1016/j.ejpain.2005.06.00916095934
   PubMed Web of Science ®Google Scholar
• Eitner A, Hofmann GO, Schaible HG. Mechanisms of osteoarthritic pain. studies in humans and experimental models. Front Mol Neurosci. 2017;10:349. doi:10.3389/fnmol.2017.0034929163027
   PubMed Web of Science ®Google Scholar
• Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage. 2013;21(9):1145–1153. doi:10.1016/j.joca.2013.03.01823973124
   PubMed Web of Science ®Google Scholar
• Cohen E, Lee Y. A mechanism-based approach to the management of osteoarthritis pain. Curr Osteoporos Rep. 2015;13:399–406. doi:10.1007/s11914-015-0291-y26419467
   PubMed Web of Science ®Google Scholar
• Thakur M, Dickenson AH, Baron R. Osteoarthritis pain: nociceptive or neuropathic? Nat Rev Rheumatol. 2014;10(6):374–380. doi:10.1038/nrrheum.2014.4724686507
   PubMed Web of Science ®Google Scholar
• Saragiotto BT, Machado GC, Ferreira ML, Pinheiro MB, Abdel Shaheed C, Maher CG. Paracetamol for low back pain. Cochrane Database Syst Rev. 2016;(6):CD012230. doi:10.1002/14651858.CD01223027271789
   PubMed Web of Science ®Google Scholar
• Machado GC, Maher CG, Ferreira PH, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350:h1225. doi:10.1136/bmj.h122525828856
   PubMed Web of Science ®Google Scholar
• Mammucari M, Gigliotti S, Pucino A, Capezza M, Santé G, On Behalf of the Ason Study Group. The management of chronic osteoarticular pain in the outpatient setting: results of an ASON audit. Joint 2015;3(3):146–150. doi:10.11138/jts/2015.3.3.146
   Google Scholar
• McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22:363–388. doi:10.1016/j.joca.2014.01.00324462672
   PubMed Web of Science ®Google Scholar
• Dell’Isola A, Steultjens M. Classification of patients with knee osteoarthritis in clinical phenotypes: data from the osteoarthritis initiative. PLoS One. 2018;13(1):e0191045. doi:10.1371/journal.pone.019104529329325
   PubMed Web of Science ®Google Scholar
• Raffa RB. Mechanistic and functional differentiation of tapentadol and tramadol. Expert Opin Pharmacother. 2012;13(10):1437. doi:10.1517/14656566.2012.69609722698264
   PubMed Web of Science ®Google Scholar
• Steigerwald I, Müller M, Kujawa J, Balblanc JC, Calvo-Alén J. Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study. J Pain Res. 2012;5:121–138. doi:10.2147/JPR.S3054022792000
   PubMedGoogle Scholar
• Nuesch E, Rutjes AW, Husni E, Welch V, Juni P. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev. 2009;(4):CD003115. doi:10.1002/14651858.CD003115.pub319821302
   PubMed Web of Science ®Google Scholar
• Gademan MG, Hofstede SN, Vliet Vlieland TP, Nelissen RG. Marang-van de Mheen PJ. Indication criteria for total hip or knee arthroplasty in osteoarthritis: a state-of-the-science overview. BMC Musculoskelet Disord. 2016;17(1):463. doi:10.1186/s12891-016-1134-427829422
   PubMed Web of Science ®Google Scholar
• Simões JL, Soares S, Sa-Couto P, et al. The influence of presurgical factors on the rehabilitation outcome of patients following hip arthroplasty. Rehabil Nurs. 2018:1. doi:10.1097/rnj.0000000000000126.
   Web of Science ®Google Scholar
• Arendt-Nielsen L, Nie H, Laursen MB, et al. Sensitization in patients with painful knee osteoarthritis. Pain. 2010;149(3):573–581. doi:10.1016/j.pain.2010.04.00320418016
   PubMed Web of Science ®Google Scholar
• Kress HG. Tapentadol and its two mechanisms of action: is there a new pharmacological class of centrally-acting analgesics on the horizon? Eur J Pain. 2010;14(8):781–783. doi:10.1016/j.ejpain.2010.06.01720659810
   PubMed Web of Science ®Google Scholar
• Tzschentke TM, Jahnel U, Kogel B, et al. Tapentadol hydrochloride: a next-generation, centrally acting analgesic with two mechanisms of action in a single molecule. Drugs Today (Barc). 2009;45:483–496.19834626
   PubMed Web of Science ®Google Scholar
• Clauw DJ, Hassett AL. The role of centralised pain in osteoarthritis. Clin Exp Rheumatol. 2017;35 Suppl 107(5):79–84.28967359
   PubMed Web of Science ®Google Scholar
• Dell’Isola A, Allan R, Smith SL, Marreiros SS, Steultjens M. Identification of clinical phenotypes in knee osteoarthritis: a systematic review of the literature. BMC Musculoskelet Disord. 2016;17(1):425. doi:10.1186/s12891-016-1134-427733199
   PubMed Web of Science ®Google Scholar
• Ghilardi JR, Freeman KT, Jimenez-Andrade JM, et al. Neuroplasticity of sensory and sympathetic nerve fibers in the painful arthritic joint. Arthritis Rheum. 2012;64:2223–2232. doi:10.1002/art.3438522246649
   PubMed Web of Science ®Google Scholar
• Coluzzi F, Fornasari D, Pergolizzi J, Romualdi P. From acute to chronic pain: tapentadol in the progressive stages of this disease entity. Eur Rev Med Pharmacol Sci. 2017;21(7):1672–1683.28429337
   PubMed Web of Science ®Google Scholar
• Morlion B, Coluzzi F, Aldington D, et al. Pain chronification: what should a non-pain medicine specialist know? Curr Med Res Opin. 2018;34(7):1169–1178. doi:10.1080/03007995.2018.144973829513044
   PubMed Web of Science ®Google Scholar
• Cherubino P. La gestione del dolore persistente in ortopedia [Management of persistent pain in orthopedics]. Minerva Ortop Traumatol. 2012;63(6):471–477. Italian.
   Google Scholar
• Scardino M. La gestione del dolore muscoloscheletrico in riabilitazione ortopedica: focus su tapentadolo [Management of musculoskeletal pain in orthopedic rehabilitation: focus on tapentadol]. Cap. 2014;13. Italian.
   Google Scholar
• Tzschentke TM, Folgering JH, Flik G, De Vry J. Tapentadol increases levels of noradrenaline in the rat spinal cord as measured by in vivo microdialysis. Neurosci Lett. 2012;507(2):151–155. doi:10.1016/j.neulet.2011.12.00822197547
   PubMed Web of Science ®Google Scholar
• Langford RM, Knaggs R, Farquhar-Smith P, Dickenson AH. Is tapentadol different from classical opioids? A review of the evidence. Br J Pain. 2016;10(4):217–221. doi:10.1177/204946371665736327867511
   PubMed Web of Science ®Google Scholar
• Afilalo M, Etropolski MS, Kuperwasser B, et al. Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study. Clin Drug Investig. 2010;30(8):489–505. doi:10.2165/11533440-000000000-00000
   PubMed Web of Science ®Google Scholar
• Steigerwald I, Schenk M, Lahne U, Gebuhr P, Falke D, Hoggart B. Effectiveness and tolerability of tapentadol prolonged release compared with prior opioid therapy for the management of severe, chronic osteoarthritis pain. Clin Drug Investig. 2013;33(9):607–619. doi:10.1007/s40261-013-0102-0
   PubMed Web of Science ®Google Scholar
• Banerjee M, Mondal S, Sarkar R, Mondal H, Bhattacharya K. Comparative study of efficacy and safety of tapentadol versus etoricoxib in mild to moderate grades of chronic osteorthritis of knee. Indian J Rheumatol. 2016;11(1):21–25. doi:10.1016/j.injr.2015.12.001
   Google Scholar
• Serrie A, Lange B, Steup A. Tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a double-blind, randomized, placebo- and oxycodone controlled release-controlled study. Curr Med Res Opin. 2017;33(8):1423–1432. doi:10.1080/03007995.2017.133518928537501
   PubMed Web of Science ®Google Scholar
• Biondi DM, Xiang J, Etropolski M, Moskovitz B. Tolerability and efficacy of tapentadol extended release in elderly patients ≥75 years of age with chronic osteoarthritis knee or low back pain. J Opioid Manag. 2015;11(5):393–403. doi:10.5055/jom.2015.028926535967
   PubMedGoogle Scholar
• Lange B, von Zabern D, Elling C, Dubois C. Efficacy and safety of tapentadol prolonged release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled release-controlled studies. Curr Med Res Opin. 2017;33(8):1413–1422. doi:10.1080/03007995.2017.133518828537506
   PubMed Web of Science ®Google Scholar
• Hartrick C, Van Hove I, Stegmann JU, Oh C, Upmalis D. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study. Clin Ther. 2009;31(2):260–271. doi:10.1016/j.clinthera.2009.02.00919302899
   PubMed Web of Science ®Google Scholar
• Vorsanger GJ, Klopfer AM, Xiang J, Benson CJ, Moskovitz BL, Rosenthal NR. Immediate-release tapentadol or oxycodone for treatment of acute postoperative pain after elective arthroscopic shoulder surgery: a randomized, phase IIIb study. J Opioid Manag. 2013;9(4):281–290. doi:10.5055/jom.2013.017024353022
   PubMedGoogle Scholar
• Haeseler G, Schaefers D, Prison N, Ahrens J, Liu X, Karch A. Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone. BMC Anesthesiol. 2017;17(1):91. doi:10.1186/s12871-017-0383-628693439
   PubMed Web of Science ®Google Scholar
• Panella L, Caserta AV, Ballarati R, Lopresti M, Parravicini L. Control of post-operative pain and rehabilitation compliance of patients undergoing knee replacement. Clinical Practice (Therapy). 2016;13:2.
   Google Scholar
• Rinonapoli G, Caraffa A Tapentadolo PR in pazienti in attesa di protesizzazione di ginocchio: valutazione pre e post intervento. 101° Congresso SIOT Torino, Italy, 10 28–31, 2016.
   Google Scholar
• Brown GA. AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg. 2013;21:577–579. doi:10.5435/JAAOS-21-09-57723996989
   PubMed Web of Science ®Google Scholar
• Faria J, Barbosa J, Moreira R, Queirós O, Carvalho F, Dinis-Oliveira RJ. Comparative pharmacology and toxicology of tramadol and tapentadol. Eur J Pain. 2018;22(5):827–844. doi:10.1002/ejp.119629369473
   PubMed Web of Science ®Google Scholar